Skip to content
Trial Eligibility
Menu

Examination of Nociscan Impact on Low Back Pain Surgical Outcomes

NCT06661850

This study is recruiting at 10 US sites in 6 states, according to its ClinicalTrials.gov record last updated .

Summary

This study is looking into how useful NOCISCAN is. NOCISCAN is a software as a Service (SaaS) tool that uses Magnetic Resonance (MR) spectroscopy. Nociscan leverages MRS to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. The randomized controlled trial will compare the blinded and unblinded cohorts and their corresponding surgical outcomes with the Nocigram reports, generated prior to treatment, for each patient.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Low Back Pain

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 70 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Aclarion
Last updated on ClinicalTrials.gov
September 10, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • University of Arizona · Phoenix, AZ

California · 3

  • Todd H. Lanman, M.D Inc · Beverly Hills, CA
  • Scripps Health · La Jolla, CA
  • USC Keck Medical Center · Los Angeles, CA

Florida · 1

  • University of Miami/ Jackson Health System · Miami, FL

Illinois · 3

  • Northwestern University · Chicago, IL
  • Endeavor Health · Evanston, IL
  • Advocate Aurora Research Institute · Park Ridge, IL

Maryland · 1

  • Johns Hopkins Medicine · Baltimore, MD

Texas · 1

  • Texas Back Institute · Plano, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.